輸入代號或公司名稱後按 Enter
4148

全宇生技-KY

+1.40 (+4.32%)最後更新 2026-09-11
台灣 · 上市 · 生技醫療業
33.80139成交張數12.25本益比0.82股價淨值比2.96%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q21.1496.7%2.730.777.8%2.78%7.20%
2026Q10.08-58.0%2.170.051.0%0.19%5.51%
2025Q40.5379.5%2.280.354.2%1.33%5.82%
2025Q30.98-8.9%2.050.698.3%2.79%5.35%
2025Q20.58368.2%2.140.364.9%1.46%6.05%
2025Q10.19-54.6%1.690.132.4%0.52%4.73%
2024Q40.301.910.202.8%0.78%5.39%
2024Q31.085.6%1.490.729.7%2.95%4.06%
2024Q20.12-78.7%1.440.081.7%0.35%4.32%
2024Q10.42-30.2%1.890.285.4%1.27%5.71%
2023Q4-0.12-117.8%2.08-0.09-1.5%-0.37%6.03%
2023Q31.02-56.9%2.890.6910.0%3.05%8.45%
2023Q20.58-58.5%4.240.394.9%1.76%13.29%
2023Q10.60-41.1%5.060.405.2%1.76%16.05%
2022Q40.70-41.1%5.480.475.3%2.00%16.90%
2022Q32.36222.1%5.961.5912.8%7.23%19.07%
2022Q21.40122.7%4.330.9410.3%4.59%14.66%
2022Q11.02154.8%3.560.6910.3%3.42%12.27%
2021Q41.18125.4%2.940.8011.9%4.09%9.96%
2021Q30.7342.6%2.290.498.9%2.57%7.98%
2021Q20.6310.0%2.070.427.5%2.24%7.40%
2021Q10.402.010.276.6%1.40%7.24%
2020Q40.522656.3%1.220.356.3%1.80%4.08%
2020Q30.51440.1%0.710.357.3%1.82%2.41%
2020Q20.5739.5%0.300.399.7%2.07%1.00%
2020Q1-0.39-4209.5%0.13-0.26-12.2%-1.34%0.44%
2019Q40.02-95.4%0.530.010.3%0.05%1.69%
2019Q30.10-93.0%0.920.061.4%0.31%2.99%
2019Q20.41-76.2%2.190.284.7%1.29%7.05%
2019Q10.01-99.1%3.500.010.1%0.02%10.79%
2018Q40.41-57.0%4.530.286.0%1.30%14.49%
2018Q31.361.4%5.080.9112.0%4.30%16.86%
2018Q21.721.1615.3%5.45%
2018Q11.040.7010.0%3.33%
2017Q40.950.6612.1%3.32%
2017Q31.340.9013.1%